Invasive aspergillosis in children with hematologic malignancies

Pediatric Drugs

Volumn 8, Issue 1, 2006, Pages 15-24

  Hasan, Rashed A ^a   Abuhammour, Walid ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b HURLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA 1,3 GLUCAN; CASPOFUNGIN; CYCLODEXTRIN; CYCLOSPORIN; ECHINOCANDIN; GALACTOMANNAN; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ASPERGILLOSIS; BLOOD VESSEL; BONE INFECTION; BRAIN; BRAIN INFECTION; CARDIORESPIRATORY INSTABILITY; CHILD; CHILDHOOD CANCER; CHILL; CLINICAL TRIAL; COLOR VISION DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG RESPONSE; FEVER; HEMATOLOGIC MALIGNANCY; HEPATITIS; HUMAN; INFECTION COMPLICATION; KIDNEY INFECTION; LUNG ASPERGILLOSIS; LUNG BIOPSY; MICROSCOPY; NEPHROTOXICITY; NEUTROPENIA; PHOTOALLERGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOGRAPHY; RASH; RESPIRATORY TRACT INFECTION; REVIEW; SEROLOGY; SIDE EFFECT; SKIN INFECTION; SURGICAL MORTALITY; TISSUE INJURY; TREATMENT FAILURE; TUBULAR DYSFUNCTION; UNSPECIFIED SIDE EFFECT; URTICARIA; VISUAL DISORDER;

ADOLESCENT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; DRUG THERAPY, COMBINATION; HEMATOLOGIC NEOPLASMS; HUMANS; TRIAZOLES;

EID: 33644514319     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200608010-00002     Document Type: Review

References (55)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805
2. Marr KA, Bowden RA. Fungal infections in patients undergoing blood and marrow transplantation. Transpl Infect Dis 1999; 1: 237-46
3. Gerson S, Talbot G, Hurwitz S, et al. Prolonged granulocytopenia; the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345-51
4. Horvath JA, Dummer S. The use of respiratory tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171-8
5. Walmsley S, Shashi D, King S, et al. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis 1993; 12: 673-82
6. Abbasi S, Shenep JL, Hughes WT, et al. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999; 29: 1210-9
7. Krasinsnki K, Holzman RS, Hanna B, et al. Nosocomial fungal infection during hospital renovation. Infect Control 1985; 6: 278-81
8. Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar airflow isolation. J Hosp Infect 1989; 14: 89-92
9. Penalver MC, Cassnove M, Martinez JP, et al. Cell wall protein and glycoprotein constituents of Aspergillus fumigatus that bind to polystyrene may be responsible for the cell surface hydrophobicity of the mycelium. Microbiology 1996; 142: 1597-604
10. Markaryan A, Morozova I, Yu H, et al. Purification and characterization of an elastinolytic metalloprotease from Aspergillus fumigatus and immunoelectron microscopic evidence of secretion of this enzyme by the fungus invading murine lung. Infect Immun 1994; 62: 2149-5
11. Golladay E, Baker S. Invasive aspergillosis in children. J Pediatr Surg 1987; 22: 504-5
12. Mahoney D, Steuber C, Starling K, et al. An outbreak of aspergillosis in children with acute leukemia. J Pediatr 1979; 95: 70-2
13. Thams KE, Owens CM, Veys PA, et al. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003; 33: 453-60
14. Gerson SL, Talbot GH, Lusk E, et al. Invasive pulmonary aspergillosis in acute leukemia: clinical clues to its diagnosis. J Clin Oncol 1985; 3: 1109-16
15. Gefter WB, Albelda SM, Talbot GH, et al. Invasive pulmonary aspergillosis in acute leukemia; limitations in the diagnostic utility of the air crescent sign. Radiology 1985; 157: 605-10
16. Taccone A, Occhi M, Garaventa A, et al. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 1993; 23: 177-80
17. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-9
18. Leutner CC, Gieseke J, Lutterbey G, et al. MR imaging of pneumonia in immunocompromised patients: comparison with helical CT. Am J Radiol 2000; 175: 391-7
19. Walsh TJ, Gonzalez C, Lyman CA, et al. Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis 1996; 11: 187-290
20. Ozsahin H, Wacker P, Brundler MA, et al. Fatal myocardial aspergillosis in an immunosuppressed child. J Pediatr Hematol Oncol 2001; 23: 456-9
21. Stammberger H, Jakse R, Beaufort F. Aspergillosis of the paranasal sinuses: x-ray diagnosis, histopathology, and clinical aspects. Ann Otol Rhinol Laryngol 1984; 93: 252-6
22. de Carpentier J, Ramamurthy M, Taylor P, et al. An algorithmic approach to Aspergillus sinusitis. J Laryngol Otol 1994; 108: 314-8
23. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinopathological analysis of 17 patients. Ann Neurol 1985; 18: 574-82
24. Walsh TJ. Primary cutaneous aspergillosis: an emerging infection among immunocompromised patients. Clin Infect Dis 1998; 27: 453-7
25. Kami M, Shiruzu I, Mitani K, et al. Early diagnosis of central nervous system aspergillosis with combination use of cerebral diffusion-weighted echo-planar magnetic resonance image and polymerase chain reaction of cerebrospinal fluid. Intern Med 1999; 38: 45-8
26. Nigro J, Gresil M, Fernback D. Value of postmortem examination in a pediatric population with leukemia. J Pediatr 1990; 116: 350-4
27. Bomelburg T, Roos N, Fegeler W, et al. Invasive aspergillosis during chemotherapy in children. Haematol Blood Transf 1994; 36: 778-81
28. Hoffer FA, Gow K, Flynn PM, et al. Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol 2001; 31: 144-52
29. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20 (7): 1898-906
30. Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis 1996; 15: 232-7
31. Obayashi T, Yoshida M, Mori T, et al. Plasma (1 to 3) beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 34: 17-20
32. Stynen D, Goris A, Sarfati J, et al. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactomannan in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500
33. Swanink CMA, Meis JF, Rijs AJ, et al. Specificity of a sandwich enzyme-linked immunosorbent assay for Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-60
34. Hebart H, Loeffler J, Meisner C, et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000; 181: 1713-9
35. Weig M, Frosch M, Tintelnot K, et al. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol 2001; 39: 1721-30
36. Singer MS, Seibel NL, Vezina G, et al. Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia. J Pediatr Hematol Oncol 2003; 25: 252-6
37. Groll A, Piscitelli S, Walsh TJ. Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Adv Pharmacol 1998; 44: 343-500
38. Wingard JR. Lipid formulations of amphotericins: are you a lumper or a splitter? Clin Infect Dis 2002; 35: 891-5
39. Bowden R, Chandrasekar P, White MH, et al. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2002; 35: 359-66
40. Denning DW, Lee JY, Hostetler JS, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97: 135-44
41. Clemons KV, Stevens DA. Comparison of Fungisome, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998; 42: 899-902
42. Wingard JR, White MH, Anaissie E, et al. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000; 31: 1155-63
43. Scarcella A, Pasquariello MB, Gugliano B, et al. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis 1998; 17: 146-8
44. Hernrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15
45. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002; 21: 240-8
46. Johnson LB, Kaufman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36: 630-7
47. Letscher-Bru V, Herbrecht R. Caspofungin: the first representative of new antifungal class. J Antimicrob Chemother 2003; 51: 513-21
48. Ernst EJ. Investigational antifungal agents. Pharmacotherapy 2001; 21: 165S-74S
49. Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002; 46: 1032-7
50. Steinbach WJ, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 2003; 37 Suppl. 3: S188-224
51. Kontoyiannis DP, Hachem R, Lewis RE, et al. Efficacy and toxicity of caspofungin/liposomal amphotericin B combination in documented or possible invasive aspergillosis in patients with hematological malignancies. Presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 2002 Sep 27-30; San Diego (CA)
52. Nishii K, Mitani H, Miyashita H, et al. Successful treatment of invasive pulmonary aspergillosis with G-CSF and M-CSF during long-term bone marrow suppression in hypoplastic leukemia. Rinsho Ketsueki 2002; 43: 189-93
53. Ozsahin H, von Planta M, Muller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998; 92 (8): 2719-24
54. Henze G, Aldenhoff P, Stephani V, et al. Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child. Eur J Pediatr 1982; 138: 263-5
55. Hovi L, Saarinen UM, Donner U. Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy. J Pediatr Hematol Oncol 1996; 18 (1): 90-4